Riskpilot← Back to searchSign inGet full accessDalaoptik AB
ABActiveOrg 5590063581Hjultorget 18Retail sale of medical and orthopaedic goods · NACE 4774Est. 20153 employees
Revenue 2025
SEK 6,2M
+10% vs 2024
EBITDA margin
13.9%
+79% vs 2024
Equity ratio
57.2%
Financial strength
Net profit 2025
SEK 680K
+81% vs 2024
| Revenue | SEK 6,2M | +10% |
| EBITDA | SEK 859K | +79% |
| Net profit | SEK 680K | +81% |
| Total assets | SEK 1,9M | +38% |
| Equity | SEK 1,1M | +43% |
| Employees | 3 | — |
Legal name
Dalaoptik AB
Org number
5590063581
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
5 mars 2015
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva leg. Optik och handel med glasögon, kontaktlinser, optiska artiklar och därmed förenlig verksamhet. Samt bedriva konsultverksamhet inom optik.
Address
Hjultorget 18
Email
optikern@hjultorget.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 708 | 5 459 | 5 325 | 5 660 | 6 200 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 636 | 600 | 17 | 479 | 859 |
| Depreciation & amort. | −45 | −22 | −22 | −5 | −3 |
| EBIT | 591 | 578 | −5 | 474 | 856 |
| Net financials | −8 | — | −1 | 1 | 1 |
| Profit before tax | 582 | 578 | −6 | 475 | 858 |
| Tax | −128 | −125 | −2 | −99 | −178 |
| Net profit | 454 | 453 | −8 | 376 | 680 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 160 | 1 618 | 1 059 | 1 400 | 1 933 |
| Equity | 505 | 808 | 399 | 775 | 1 105 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 655 | 810 | 660 | 625 | 829 |
| Total debt | 655 | 810 | 660 | 625 | 829 |
EBITDA margin
13.9%
This company
15.8%
Market median
-12% vs market
20212025
Equity ratio
57.2%
This company
38.2%
Market median
+50% vs market
20212025
Return on equity
61.5%
This company
18.4%
Market median
+234% vs market
20212025
Net profit margin
11.0%
This company
8.1%
Market median
+36% vs market
20212025
Asset turnover
3.21×
This company
1.12×
Market median
+187% vs market
20212025
Debt / equity
0.75×
This company
0.62×
Market median
+21% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JP Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
EA | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dalaoptik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Patrik Gilljam | Chief Auditor | 0 companies |
| Erik Arne Henry Berglund | Audit | 0 companies |
| Veronica Alice Elizabeth Norrby | Board of Directors | 0 companies |
| Nils Stephan Norrby | Deputy Board Member | 0 companies |
| Karl Åke Jonas Danielsson | Deputy Board Member | 0 companies |